Retinal Vasoproliferative Tumours in Uveitis.

IF 2.6 4区 医学 Q2 OPHTHALMOLOGY
Ocular Immunology and Inflammation Pub Date : 2024-11-01 Epub Date: 2024-02-29 DOI:10.1080/09273948.2024.2317418
Arshee S Ahmed, Parthopratim Dutta Majumder, Amala Elizabeth, Vinita Rao, Sudha Ganesh, Jyotirmay Biswas
{"title":"Retinal Vasoproliferative Tumours in Uveitis.","authors":"Arshee S Ahmed, Parthopratim Dutta Majumder, Amala Elizabeth, Vinita Rao, Sudha Ganesh, Jyotirmay Biswas","doi":"10.1080/09273948.2024.2317418","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To describe a cohort of patients with retinal vasoproliferative tumours (RVPT) seen in the uveitis clinic of a single tertiary eye care institute in India.</p><p><strong>Methods: </strong>Retrospective Chart Review.</p><p><strong>Results: </strong>In our study of 17 patients with 18 eyes affected by RVPTs, 94.1% showed unilateral involvement, one patient had bilateral RVPTs, and another had two RVPTs in the same eye. The mean age was 36.3 ± 15.1 years (range: 12-63 years), with a male majority (76.4%). The most common location was inferotemporal quadrant (44.4%). The most common associated uveitic condition was intermediate uveitis (50%). Patients were treated with oral corticosteroid (in 94.1%) and immunosuppressive (35.2%) in addition to transconjunctival cryotherapy (in 52.9%) or laser photocoagulation (in 41.1%). Regression of the RVPT was achieved in all cases except one. Visual acuity at time of detection of RVPT ranged from 6/6 to HM. No significant change was noted in the mean best corrected visual acuity pre and post treatment in the study group.</p><p><strong>Conclusion: </strong>RVPTs, rare peripheral retinal lesions often associated with intermediate uveitis, require early diagnosis with targeted therapy to prevent vision loss and achieve favorable long-term outcomes with rare recurrences.</p>","PeriodicalId":19406,"journal":{"name":"Ocular Immunology and Inflammation","volume":" ","pages":"2056-2060"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ocular Immunology and Inflammation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09273948.2024.2317418","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/29 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To describe a cohort of patients with retinal vasoproliferative tumours (RVPT) seen in the uveitis clinic of a single tertiary eye care institute in India.

Methods: Retrospective Chart Review.

Results: In our study of 17 patients with 18 eyes affected by RVPTs, 94.1% showed unilateral involvement, one patient had bilateral RVPTs, and another had two RVPTs in the same eye. The mean age was 36.3 ± 15.1 years (range: 12-63 years), with a male majority (76.4%). The most common location was inferotemporal quadrant (44.4%). The most common associated uveitic condition was intermediate uveitis (50%). Patients were treated with oral corticosteroid (in 94.1%) and immunosuppressive (35.2%) in addition to transconjunctival cryotherapy (in 52.9%) or laser photocoagulation (in 41.1%). Regression of the RVPT was achieved in all cases except one. Visual acuity at time of detection of RVPT ranged from 6/6 to HM. No significant change was noted in the mean best corrected visual acuity pre and post treatment in the study group.

Conclusion: RVPTs, rare peripheral retinal lesions often associated with intermediate uveitis, require early diagnosis with targeted therapy to prevent vision loss and achieve favorable long-term outcomes with rare recurrences.

葡萄膜炎中的视网膜血管增生性肿瘤。
目的:描述在印度一家三级眼科医院葡萄膜炎诊所就诊的视网膜血管增生性肿瘤(RVPT)患者群体:方法:回顾性病历审查:在我们的研究中,17 名患者的 18 只眼睛受到 RVPT 的影响,94.1% 的患者为单侧受累,一名患者为双侧 RVPT,另一名患者在同一只眼睛中有两个 RVPT。患者平均年龄为 36.3 ± 15.1 岁(12-63 岁),男性占多数(76.4%)。最常见的发病部位是颞下象限(44.4%)。最常见的葡萄膜炎症是中间葡萄膜炎(50%)。除了经结膜冷冻疗法(52.9%)或激光光凝疗法(41.1%)外,患者还接受了口服皮质类固醇(94.1%)和免疫抑制剂(35.2%)治疗。除一例病例外,其他病例的 RVPT 均已消退。发现 RVPT 时的视力从 6/6 到 HM 不等。研究组治疗前后的平均最佳矫正视力无明显变化:RVPT是一种罕见的视网膜周边病变,通常与中间葡萄膜炎相关,需要早期诊断和针对性治疗,以防止视力丧失,并获得良好的长期疗效和罕见的复发率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
15.20%
发文量
285
审稿时长
6-12 weeks
期刊介绍: Ocular Immunology & Inflammation ranks 18 out of 59 in the Ophthalmology Category.Ocular Immunology and Inflammation is a peer-reviewed, scientific publication that welcomes the submission of original, previously unpublished manuscripts directed to ophthalmologists and vision scientists. Published bimonthly, the journal provides an international medium for basic and clinical research reports on the ocular inflammatory response and its control by the immune system. The journal publishes original research papers, case reports, reviews, letters to the editor, meeting abstracts, and invited editorials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信